Rongfeng Holdings disclosed on May 7, 2024 in the interactive trade of the Shenzhen Stock Exchange that as of April 30, 2024, the number of shareholders of the company was 8,572, an increase of 507 from the previous period (March 31, 2024), an increase of 6.29%.
The number of Rongfeng controlling shareholders is lower than the industry average. According to Choice data, as of April 30, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry was 33,900. Among them, the number of shareholders of the company is in the range of 5,000 ~ 15,000, accounting for the highest proportion, 28.84%, and Rongfeng Holdings is also in the range.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since January 31, 2024, the number of shareholders of the company has increased, with an increase of 6.25%. From January 31, 2024 to April 30, 2024, the stock price decreased by 17.12%.
Number of shareholders and share price
Number of shareholders and share capital
As of April 30, 2024, the company's latest total share capital is 147 million shares, all of which are outstanding shares. The average number of outstanding shares held by households decreased from 18,200 shares in the previous period to 17,100 shares, and the average market value of households was 124,400 yuan.
The average amount of shares held by each household
The average circulating market value held by Rongfeng holders is lower than the industry average. According to Choice data, as of April 30, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry was 401,500 yuan. Among them, 25.10% of the company's households hold a circulating stock market value in the range of 130,000~250,000.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.